David J. Brillon, M.D.

Endocrinology, Diabetes and Metabolism

Publications

EDIC Research Group. Epidemiology of Diabetes Interventions and Complications (EDIC): Design and implementation of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999; 22:99-111.
 

EDIC Research Group. Prolonged effect of intensive therapy on the risk of advanced complications in the Epidemiology of Diabetes Interventions and Complications (EDIC). NEJM 2000; 342:381-389.
 

Matthews DE, Harkin R, Battezati A and Brillon DJ. Splanchnic bed utilization of enteral alpha-keto-isocaproate in humans. Metabolism 1999; 48:1555-1563.
 

Poretsky L, Lesser M, Brillon D. Lack of postprandial leptin peaks in patients with type 2 diabetes mellitus. Diab Obes Metab 2000; 2:1-7.
 

DCCT/EDIC Research Group. Intensive diabetes therapy and carotid artery thickness in type 1 diabetes mellitus. NEJM 2003; 348:2294-2303.

Brillon DJ,Sison CP, Salbe AD, Poretsky L. Reproducibilty of a Glycemic Response to Mixed Meals in Type 2 Diabetes Mellitus. Horm Metab Res 2006; 38:536-542

Poretsky L, Brillon DJ, Ferrando S, Chui J, McELhiney , Ferenzi A, Sison CP, Haller I, Rabkin J. Endocrine effects of oral dhydroepiandosterone in men with HIV infection: a prospective , randomized, double-blind, placebo-controlled trial. Metabolism 2006; 55:858-870

Kern LM, Callahan MA, Brillon DJ, Vargas M, Mushlin, Al.  Glucose testing and insufficient follow-up of abnormal results: a cohort study.  BMC Health Serv res 6:87-92, 2006

Lubitz CC, Seley JJ, Rivera C, Sinha N, Brillon DJ.  the perils of inpatient hyperglycemia management: How we turned apathy into action.  Diabetes Spectrum 20:18-21, 2007

Bonds DE, Kurashige EM, Burgenstal R, Brillon D, Domanski M, Felicetta JV, Fonseca VA, Hall K, Hramiak I, Miller ME, Osei K, Simons-Morton DG. Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.  Am J Cardiol 2007; 99(S):80i-89i

ACCORD Study Group.  Effects of intensive glucose lowering in type 2 diabetes. N Eng J Med 358: 2545-2559

 

Back to topBack To Top